Skip to main content
Erschienen in: World Journal of Urology 6/2013

01.12.2013 | Original Article

The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection

verfasst von: Jian-Ye Liu, Yong-Hong Li, Zhi-Ling Zhang, Kai Yao, Yun-Lin Ye, Dan Xie, Hui Han, Zhou-Wei Liu, Zi-Ke Qin, Fang-Jian Zhou

Erschienen in: World Journal of Urology | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Objective

To evaluate factors in penile squamous cell carcinoma predictive of pelvic lymph node metastasis and survival.

Materials and methods

Data were collected and analyzed retrospectively in 146 patients with squamous cell carcinoma of penis who underwent bilateral inguinal lymph node dissection in our center between January 1998 and April 2011. Variables recorded included serum squamous cell carcinoma antigen, primary tumor p53 immunoreactivity, histological grade, pathological tumor stage, lymphatic or vascular invasion, absent/unilateral or bilateral inguinal lymph node involvement, number of metastatic inguinal lymph nodes, presence of extracapsular growth and lymph node density.

Results

Seventy patients had inguinal lymph node metastasis (LNM). Of these, 33 (47.1 %) had pelvic LNM. Primary tumor strong p53 expression, lymphatic or vascular invasion, involvement of more than two inguinal lymph nodes and 30 % or greater lymph node density were significant predictors of pelvic LNM. Primary tumor strong p53 expression (odds ratio [OR] 5.997, 95 % confidence intervals [CI] 1.615–22.275), presence of extracapsular growth (OR 2.209, 95 % CI 1.166–4.184), involvement of more than two inguinal lymph nodes (OR 2.494, 95 % CI 1.086–5.728) and pelvic lymph node involvement (OR 18.206, 95 % CI 6.807–48.696) were independent prognostic factors for overall survival.

Conclusions

Primary tumor expression of p53, lymphatic or vascular invasion, number of metastatic inguinal lymph nodes and lymph node density were all predictors of pathologic pelvic lymph node involvement. Patients with pelvic LNM had an adverse prognosis, with a 3-year overall survival rate of approximately 12.1 %. Pelvic lymph node dissection should be considered in these cases.
Literatur
1.
Zurück zum Zitat Novara G, Galfano A, DeMarco V et al (2007) Prognostic factors in squamous cell carcinoma of the penis. Nat Clin Pract Urol 4:140–146PubMedCrossRef Novara G, Galfano A, DeMarco V et al (2007) Prognostic factors in squamous cell carcinoma of the penis. Nat Clin Pract Urol 4:140–146PubMedCrossRef
2.
Zurück zum Zitat Misra S, Chaturvedi A, Misra NC (2004) Penile carcinoma: a challenge for the developing world. Lancet Oncol 5:240–247PubMedCrossRef Misra S, Chaturvedi A, Misra NC (2004) Penile carcinoma: a challenge for the developing world. Lancet Oncol 5:240–247PubMedCrossRef
3.
Zurück zum Zitat Kroon BK, Horemblas S, Niewec OE (2005) Contemporary management of penile squamous cell carcinoma. J Surg Oncol 89:43–50PubMedCrossRef Kroon BK, Horemblas S, Niewec OE (2005) Contemporary management of penile squamous cell carcinoma. J Surg Oncol 89:43–50PubMedCrossRef
4.
Zurück zum Zitat Cabañas RM (1992) Anatomy and biopsy of sentinel lymph nodes. Urol Clin North Am 19:267–276PubMed Cabañas RM (1992) Anatomy and biopsy of sentinel lymph nodes. Urol Clin North Am 19:267–276PubMed
5.
Zurück zum Zitat Senthil Kumar MP, Ananthakrishnan N, Prema V (1998) Predicting regional lymph node metastasis in carcinoma of the penis: a comparison between fine-needle aspiration cytology, sentinel lymph node biopsy and medial inguinal lymph node biopsy. Br J Urol 81:453–457PubMedCrossRef Senthil Kumar MP, Ananthakrishnan N, Prema V (1998) Predicting regional lymph node metastasis in carcinoma of the penis: a comparison between fine-needle aspiration cytology, sentinel lymph node biopsy and medial inguinal lymph node biopsy. Br J Urol 81:453–457PubMedCrossRef
6.
Zurück zum Zitat Srinivas V, Morse MJ, Herr HW et al (1987) Penile cancer: relation of extent of nodal metastasis to survival. J Urol 137:880–882PubMed Srinivas V, Morse MJ, Herr HW et al (1987) Penile cancer: relation of extent of nodal metastasis to survival. J Urol 137:880–882PubMed
7.
Zurück zum Zitat Ravi R (1993) Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol 72:817–819PubMedCrossRef Ravi R (1993) Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol 72:817–819PubMedCrossRef
8.
Zurück zum Zitat Pandey D, Mahajan V, Kannan RR (2006) Prognostic factors in node-positive carcinoma of the penis. J Surg Oncol 93:133–138PubMedCrossRef Pandey D, Mahajan V, Kannan RR (2006) Prognostic factors in node-positive carcinoma of the penis. J Surg Oncol 93:133–138PubMedCrossRef
9.
Zurück zum Zitat Lopes A, Bezerra AL, Serrano SV et al (2000) Iliac nodal metastases from carcinoma of the penis treated surgically. BJU Int 86:690–693PubMedCrossRef Lopes A, Bezerra AL, Serrano SV et al (2000) Iliac nodal metastases from carcinoma of the penis treated surgically. BJU Int 86:690–693PubMedCrossRef
10.
Zurück zum Zitat Graafland NM, van Boven HH, van Werkhoven E et al (2010) Prognostic significance of extranodal extension in patients with pathological node positive penile carcinoma. J Urol 184:1347–1353PubMedCrossRef Graafland NM, van Boven HH, van Werkhoven E et al (2010) Prognostic significance of extranodal extension in patients with pathological node positive penile carcinoma. J Urol 184:1347–1353PubMedCrossRef
11.
Zurück zum Zitat Horenblas S, van Tinteren H, Delemarre JF et al (1991) Squamous cell carcinoma of the penis: accuracy of tumor, nodes and metastasis classification system, and role of lymphangiography, computerized tomography scan and fine needle aspiration cytology. J Urol 146:1279–1283PubMed Horenblas S, van Tinteren H, Delemarre JF et al (1991) Squamous cell carcinoma of the penis: accuracy of tumor, nodes and metastasis classification system, and role of lymphangiography, computerized tomography scan and fine needle aspiration cytology. J Urol 146:1279–1283PubMed
12.
Zurück zum Zitat Zhu Y, Zhang SL, Ye DW et al (2008) Predicting pelvic lymph node metastases in penile cancer patients: a comparison of computed tomography, Cloquet’s node, and disease burden of inguinal lymph nodes. Onkologie 31:37–41PubMedCrossRef Zhu Y, Zhang SL, Ye DW et al (2008) Predicting pelvic lymph node metastases in penile cancer patients: a comparison of computed tomography, Cloquet’s node, and disease burden of inguinal lymph nodes. Onkologie 31:37–41PubMedCrossRef
13.
Zurück zum Zitat Lont AP, Besnard AP, Gallee MP et al (2003) A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int 91:493–495PubMedCrossRef Lont AP, Besnard AP, Gallee MP et al (2003) A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int 91:493–495PubMedCrossRef
14.
Zurück zum Zitat Hughes B, Leijte J, Shabbir M et al (2009) Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer. World J Urol 27:197–203PubMedCrossRef Hughes B, Leijte J, Shabbir M et al (2009) Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer. World J Urol 27:197–203PubMedCrossRef
15.
Zurück zum Zitat Sánchez-Ortiz RF, Pettaway CA (2004) The role of lymphadenectomy in penile cancer. Urol Oncol 22:236–245PubMedCrossRef Sánchez-Ortiz RF, Pettaway CA (2004) The role of lymphadenectomy in penile cancer. Urol Oncol 22:236–245PubMedCrossRef
16.
Zurück zum Zitat Lont AP, Kroon BK, Gallee MP et al (2007) Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. J Urol 177:947–952PubMedCrossRef Lont AP, Kroon BK, Gallee MP et al (2007) Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. J Urol 177:947–952PubMedCrossRef
17.
Zurück zum Zitat Yao K, Tu H, Li YH et al (2010) Modified technique of radical inguinal lymphadenectomy for penile carcinoma: morbidity and outcome. J Urol 184:546–552PubMedCrossRef Yao K, Tu H, Li YH et al (2010) Modified technique of radical inguinal lymphadenectomy for penile carcinoma: morbidity and outcome. J Urol 184:546–552PubMedCrossRef
19.
Zurück zum Zitat Greene FL, Page DL, Fleming ID et al (2002) Penis. In: Cancer AJCC (ed) Staging manual. Springer, New York, pp 303–310CrossRef Greene FL, Page DL, Fleming ID et al (2002) Penis. In: Cancer AJCC (ed) Staging manual. Springer, New York, pp 303–310CrossRef
20.
Zurück zum Zitat Bezerra ALR, Lopes A, Santiago GH et al (2001) Human papillomavirus as a prognostic factor in carcinoma of the penis. Cancer 91:2315–2321PubMedCrossRef Bezerra ALR, Lopes A, Santiago GH et al (2001) Human papillomavirus as a prognostic factor in carcinoma of the penis. Cancer 91:2315–2321PubMedCrossRef
21.
Zurück zum Zitat Horenblas S, van Tinteren H, Delemarre JF et al (1993) Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol 149:492–497PubMed Horenblas S, van Tinteren H, Delemarre JF et al (1993) Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol 149:492–497PubMed
22.
Zurück zum Zitat Graafland NM, Leijte JA, Valdes Olmos RA et al (2009) Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma. Eur Urol 56:339–345PubMedCrossRef Graafland NM, Leijte JA, Valdes Olmos RA et al (2009) Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma. Eur Urol 56:339–345PubMedCrossRef
23.
Zurück zum Zitat Lopes A, Bezerra AL, Pinto CA et al (2002) P53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J Urol 168:81–86PubMedCrossRef Lopes A, Bezerra AL, Pinto CA et al (2002) P53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J Urol 168:81–86PubMedCrossRef
24.
Zurück zum Zitat Chen X, Li X, Garcia MM et al (2012) Prognostic factors in Chinese patients with penile invasive squamous cell carcinoma. J Androl 33:1276–1281PubMedCrossRef Chen X, Li X, Garcia MM et al (2012) Prognostic factors in Chinese patients with penile invasive squamous cell carcinoma. J Androl 33:1276–1281PubMedCrossRef
25.
Zurück zum Zitat Pizzocaro G, Piva L (1988) Adjuvant and neoadjuvant vincristine, bleomycin and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 27:823–824PubMedCrossRef Pizzocaro G, Piva L (1988) Adjuvant and neoadjuvant vincristine, bleomycin and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 27:823–824PubMedCrossRef
26.
Zurück zum Zitat Franks KN, Kancherla K, Sethugavalar B et al (2011) Radiotherapy for node positive penile cancer: experience of The Leeds Teaching Hospitals. J Urol 186:524–529PubMedCrossRef Franks KN, Kancherla K, Sethugavalar B et al (2011) Radiotherapy for node positive penile cancer: experience of The Leeds Teaching Hospitals. J Urol 186:524–529PubMedCrossRef
Metadaten
Titel
The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection
verfasst von
Jian-Ye Liu
Yong-Hong Li
Zhi-Ling Zhang
Kai Yao
Yun-Lin Ye
Dan Xie
Hui Han
Zhou-Wei Liu
Zi-Ke Qin
Fang-Jian Zhou
Publikationsdatum
01.12.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 6/2013
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-013-1024-4

Weitere Artikel der Ausgabe 6/2013

World Journal of Urology 6/2013 Zur Ausgabe

Neu im Fachgebiet Urologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Prostatakarzinom: EU initiiert neues Screeningkonzept

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Blasenkarzinom – Biomarker statt Zytologie?

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.